ATE234300T1 - Benzonaphthyridine als bronchialtherapeutika - Google Patents

Benzonaphthyridine als bronchialtherapeutika

Info

Publication number
ATE234300T1
ATE234300T1 AT97950093T AT97950093T ATE234300T1 AT E234300 T1 ATE234300 T1 AT E234300T1 AT 97950093 T AT97950093 T AT 97950093T AT 97950093 T AT97950093 T AT 97950093T AT E234300 T1 ATE234300 T1 AT E234300T1
Authority
AT
Austria
Prior art keywords
pct
benzonaphthyridines
bronchial therapeutics
date
sec
Prior art date
Application number
AT97950093T
Other languages
English (en)
Inventor
Beate Schmidt
Hermann Amschler
Wolf-Ruediger Ulrich
Thomas Martin
Thomas Baer
Armin Hatzelmann
Karl Sanders
Rolf Beume
Hildegard Boss
Dietrich Haefner
Hans-Peter Kley
Karl-Josef Goebel
Dieter Flockerzi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE234300T1 publication Critical patent/ATE234300T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT97950093T 1996-11-11 1997-11-05 Benzonaphthyridine als bronchialtherapeutika ATE234300T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (1)

Publication Number Publication Date
ATE234300T1 true ATE234300T1 (de) 2003-03-15

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950093T ATE234300T1 (de) 1996-11-11 1997-11-05 Benzonaphthyridine als bronchialtherapeutika

Country Status (30)

Country Link
US (1) US6008215A (de)
EP (1) EP0937074B1 (de)
JP (1) JP4223075B2 (de)
KR (1) KR100484045B1 (de)
CN (1) CN1090188C (de)
AT (1) ATE234300T1 (de)
AU (1) AU733129B2 (de)
BG (1) BG63695B1 (de)
BR (1) BR9713338B1 (de)
CA (1) CA2270964C (de)
CY (1) CY2476B1 (de)
CZ (1) CZ288752B6 (de)
DE (1) DE69719778T2 (de)
DK (1) DK0937074T3 (de)
EA (1) EA001551B1 (de)
EE (1) EE03829B1 (de)
ES (1) ES2195189T3 (de)
GE (1) GEP20012390B (de)
HU (1) HU226981B1 (de)
ID (1) ID22042A (de)
IL (1) IL129054A (de)
NO (1) NO312764B1 (de)
NZ (1) NZ334976A (de)
PL (1) PL189641B1 (de)
PT (1) PT937074E (de)
RS (1) RS49607B (de)
SI (1) SI0937074T1 (de)
SK (1) SK283269B6 (de)
TR (1) TR199900856T2 (de)
WO (1) WO1998021208A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1075477T1 (en) 1998-05-05 2003-08-31 Altana Pharma Ag Novel Benzonaphthyridine-N-oxides
JP2002523505A (ja) * 1998-08-31 2002-07-30 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド
IT1303272B1 (it) * 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
DE60033918D1 (de) 1999-01-15 2007-04-26 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
WO2000042017A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides with pde-iv inhibiting activity
DE60024581T2 (de) * 1999-01-15 2006-08-10 Altana Pharma Ag 6-phenylphenanthridine mit pde-iv hemmender wirkung
CA2359449A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
CA2438717C (en) * 2001-02-21 2011-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
AU2003263216A1 (en) * 2002-08-17 2004-03-11 Nycomed Gmbh Benzonaphthyridines with PDE 3/4 inhibiting activity
HRP20050293A2 (en) 2002-09-04 2006-07-31 Altana Pharma Ag Novel benzonaphthyridines
JP4638736B2 (ja) * 2002-09-04 2011-02-23 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のベンゾナフチリジン
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
SG182194A1 (en) 2004-03-03 2012-07-30 Nycomed Gmbh Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
NZ549254A (en) * 2004-03-10 2010-06-25 Nycomed Gmbh Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
US7671068B2 (en) 2004-03-17 2010-03-02 Nycomed Gmbh N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
JP5009799B2 (ja) * 2004-09-08 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の３−オキサ−１０−アザ−フェナントレン
WO2006027345A2 (en) * 2004-09-08 2006-03-16 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
SI1856093T1 (sl) 2005-03-02 2010-03-31 Nycomed Gmbh Hidrokloridna sol R aR bR dimetoksipiridin il etoksi metoksi a b heksahidrofenantridin ola
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
US7956064B2 (en) * 2006-09-01 2011-06-07 Cylene Pharmaceuticals, Inc. Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (de) * 1986-05-29 1990-01-17 Sandoz Ag Pharmazeutische Zusammensetzungen mit, und Verwendung von Cis-6-(4-Acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
HUP0000426A2 (hu) 2001-02-28
BG63695B1 (bg) 2002-09-30
SK283269B6 (sk) 2003-04-01
SK62399A3 (en) 1999-10-08
CZ288752B6 (cs) 2001-08-15
KR100484045B1 (ko) 2005-04-20
HUP0000426A3 (en) 2001-04-28
PT937074E (pt) 2003-07-31
EP0937074A1 (de) 1999-08-25
NO312764B1 (no) 2002-07-01
BR9713338B1 (pt) 2009-12-01
AU5317098A (en) 1998-06-03
BG103310A (en) 2000-05-31
DE69719778D1 (de) 2003-04-17
EE03829B1 (et) 2002-08-15
EA001551B1 (ru) 2001-04-23
HU226981B1 (hu) 2010-04-28
NO992282D0 (no) 1999-05-11
BR9713338A (pt) 2000-05-09
PL189641B1 (pl) 2005-09-30
SI0937074T1 (en) 2003-08-31
JP4223075B2 (ja) 2009-02-12
DK0937074T3 (da) 2003-06-23
EE9900105A (et) 1999-10-15
JP2001503442A (ja) 2001-03-13
CY2476B1 (en) 2005-05-03
CN1236367A (zh) 1999-11-24
AU733129B2 (en) 2001-05-10
WO1998021208A1 (en) 1998-05-22
PL333429A1 (en) 1999-12-06
IL129054A (en) 2002-07-25
CZ167599A3 (cs) 1999-11-17
EP0937074B1 (de) 2003-03-12
TR199900856T2 (xx) 1999-07-21
CA2270964A1 (en) 1998-05-22
NZ334976A (en) 2000-10-27
DE69719778T2 (de) 2004-02-05
YU19499A (sh) 2001-09-28
ID22042A (id) 1999-08-26
ES2195189T3 (es) 2003-12-01
US6008215A (en) 1999-12-28
CN1090188C (zh) 2002-09-04
EA199900421A1 (ru) 1999-10-28
RS49607B (sr) 2007-06-04
NO992282L (no) 1999-05-11
CA2270964C (en) 2007-07-31
KR20000053100A (ko) 2000-08-25
GEP20012390B (en) 2001-03-25
HK1022151A1 (en) 2000-07-28
IL129054A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DE69719778D1 (de) Benzonaphthyridine als bronchialtherapeutika
DK0882021T3 (da) Nye phenanthridiner
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
CA2297911A1 (en) Substituted 6-phenylphenanthridines
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DE59909760D1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ATE294793T1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
ATE315029T1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
DE69522332D1 (de) 1,4-dihydropyridine als bradykinin antagonisten
TR200100133T2 (tr) FKBP İnhibitörleri
DE59711147D1 (de) Neue Imidazo- und Oxazolopyridine als Phosphodiesterase Inhibitoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0937074

Country of ref document: EP

EEIH Change in the person of patent owner